J. David Lawson

8.2k total citations · 3 hit papers
41 papers, 5.3k citations indexed

About

J. David Lawson is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Oncology. According to data from OpenAlex, J. David Lawson has authored 41 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 5 papers in Cardiology and Cardiovascular Medicine and 5 papers in Oncology. Recurrent topics in J. David Lawson's work include Protein Structure and Dynamics (6 papers), RNA and protein synthesis mechanisms (5 papers) and Cardiomyopathy and Myosin Studies (4 papers). J. David Lawson is often cited by papers focused on Protein Structure and Dynamics (6 papers), RNA and protein synthesis mechanisms (5 papers) and Cardiomyopathy and Myosin Studies (4 papers). J. David Lawson collaborates with scholars based in United States, Japan and Australia. J. David Lawson's co-authors include Zoran Obradović, Celeste J. Brown, Lilia M. Iakoucheva, A. Keith Dunker, A. Keith Dunker, Jeong Seok Oh, K. W. Hipps, Michael D. Griswold, Andrew Campen and Pedro Romero and has published in prestigious journals such as Journal of Biological Chemistry, Bioinformatics and Journal of Molecular Biology.

In The Last Decade

J. David Lawson

40 papers receiving 5.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Intrinsically disordered protein

2001 1.8k citations A. Keith Dunker, J. David Lawson et al. Journal of Molecular Graphics and Modelling profile →
Intrinsic Disorder and Protein Function

2002 1.4k citations A. Keith Dunker, Celeste J. Brown et al. profile →
Intrinsic Disorder in Cell-signaling and Cancer-associated Proteins

2002 989 citations Lilia M. Iakoucheva, Celeste J. Brown et al. Journal of Molecular Biology profile →

Peers

Countries citing papers authored by J. David Lawson

Since Specialization

Citations

This map shows the geographic impact of J. David Lawson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. David Lawson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. David Lawson more than expected).

Fields of papers citing papers by J. David Lawson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. David Lawson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. David Lawson. The network helps show where J. David Lawson may publish in the future.

Co-authorship network of co-authors of J. David Lawson

This figure shows the co-authorship network connecting the top 25 collaborators of J. David Lawson. A scholar is included among the top collaborators of J. David Lawson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. David Lawson. J. David Lawson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Exploration of Cryptic Pockets Using Enhanced Sampling Along Normal Modes: A Case Study of KRAS ^G12D 2024 ·Journal of Chemical Information and Modeling ·Neha Vithani, She Zhang, Jeffrey P. Thompson, (unknown), (unknown), Junchao Xia, Alexander Balaeff, Ahmet Mentes, Yelena A. Arnautova, Anna Kohlmann, J. David Lawson, Anthony Nicholls, A. Geoffrey Skillman, David N. LeBard	9
2	Selected Approaches to Disrupting Protein–Protein Interactions within the MAPK/RAS Pathway 2023 ·International Journal of Molecular Sciences ·Stephen J. Harwood, Christopher R. Smith, J. David Lawson, John M. Ketcham	7
3	Discovery of Potent, Selective, and Brain-Penetrant 1H-Pyrazol-5-yl-1H-pyrrolo[2,3-b]pyridines as Anaplastic Lymphoma Kinase (ALK) Inhibitors 2019 ·Journal of Medicinal Chemistry ·Makoto Fushimi, Ikuo Fujimori, Takeshi Wakabayashi, Tomoaki Hasui, Youichi Kawakita, (unknown), Tomoko Kato, (unknown), Tsuyoshi Ishii, (unknown), (unknown), Atsushi Nakatani, (unknown), Maki Miyamoto, Kumar Singh Saikatendu, Hua Zou, (unknown), J. David Lawson, Hiroshi Imoto	18
4	MET Tyrosine Kinase Inhibition Enhances the Antitumor Efficacy of an HGF Antibody 2017 ·Molecular Cancer Therapeutics ·(unknown), (unknown), Deepika Balakrishna, Shweta Pandya, Mark S. Hixon, Ruhi Kamran, (unknown), J. David Lawson, Kengo Okada, Akira Hori, Akio Mizutani, Hidehisa Iwata, Ron de Jong, Barbara Hibner, Patrick W. Vincent	11
5	Identification of AHCY inhibitors using novel high-throughput mass spectrometry 2017 ·Biochemical and Biophysical Research Communications ·Noriko Uchiyama, Douglas R. Dougan, J. David Lawson, H. Kimura, Shin-ichi Matsumoto, (unknown), Tomohiro Kawamoto	9
6	Design, synthesis and optimization of 7-substituted-pyrazolo[4,3-b]pyridine ALK5 (activin receptor-like kinase 5) inhibitors 2017 ·Bioorganic & Medicinal Chemistry Letters ·M. Sabat, Haixia Wang, (unknown), J. David Lawson, (unknown), Ruhi Kamran, Mark S. Hixon, Douglas R. Dougan	18
7	Discovery of potent, reversible MetAP2 inhibitors via fragment based drug discovery and structure based drug design—Part 1 2016 ·Bioorganic & Medicinal Chemistry Letters ·Zacharia S. Cheruvallath, (unknown), Christopher M. McBride, (unknown), (unknown), (unknown), (unknown), Jun Feng, (unknown), J. David Lawson, Darin Vanderpool, Yiqin Wu, Douglas R. Dougan, Artur Płonowski, (unknown), Christopher J. Larson	12
8	Discovery of potent, reversible MetAP2 inhibitors via fragment based drug discovery and structure based drug design—Part 2 2016 ·Bioorganic & Medicinal Chemistry Letters ·Christopher M. McBride, Zacharia S. Cheruvallath, (unknown), (unknown), (unknown), J. David Lawson, Darin Vanderpool, Yiqin Wu, Douglas R. Dougan, Artur Płonowski, (unknown), Christopher J. Larson	18
9	Design, synthesis and optimization of novel Alk5 (activin-like kinase 5) inhibitors 2016 ·Bioorganic & Medicinal Chemistry Letters ·Haixia Wang, J. David Lawson, (unknown), Ruhi Kamran, Mark S. Hixon, (unknown), Douglas R. Dougan, M. Sabat	10
10	Fragment-based drug discovery of potent and selective MKK3/6 inhibitors 2015 ·Bioorganic & Medicinal Chemistry Letters ·Mark E. Adams, Toshitake Kobayashi, J. David Lawson, Morihisa Saitoh, Kenichiro Shimokawa, (unknown), Mark S. Hixon, Christopher R. Smith, (unknown), (unknown), Joseph Russo, Charles E. Grimshaw, (unknown)	21
11	Residence time and kinetic efficiency analysis of extracellular signal-regulated kinase 2 inhibitors 2014 ·Analytical Biochemistry ·Darin Vanderpool, Charles E. Grimshaw, J. David Lawson, Jacques Ermolieff	1
12	Comparison of Bruce Treadmill Exercise Test Protocols: Is Ramped Bruce Equal or Superior to Standard Bruce in Producing Clinically Valid Studies for Patients Presenting for Evaluation of Cardiac Ischemia or Arrhythmia with Body Mass Index Equal to or Greater Than 30? 2013 ·Journal of Nuclear Medicine Technology ·(unknown), J. David Lawson, Thomas Wasser, (unknown)	16
13	A Back-to-Front Fragment-Based Drug Design Search Strategy Targeting the DFG-Out Pocket of Protein Tyrosine Kinases 2012 ·ACS Medicinal Chemistry Letters ·Hidehisa Iwata, Hideyuki Oki, Kengo Okada, Terufumi Takagi, Michiko Tawada, Yasushi Miyazaki, Shinichi Imamura, Akira Hori, J. David Lawson, Mark S. Hixon, Hiroyuki Kimura, Hiroshi Miki	25
14	DisProt: a database of protein disorder 2004 ·Bioinformatics ·Slobodan Vučetić, Zoran Obradović, Vladimir Vacic, Predrag Radivojac, Kang Peng, Lilia M. Iakoucheva, Marc S. Cortese, J. David Lawson, Celeste J. Brown, (unknown), (unknown), A. Keith Dunker	185
15	Molecular Dynamics Analysis of Structural Factors Influencing Back Door Pi Release in Myosin 2004 ·Biophysical Journal ·J. David Lawson, Edward Pate, Ivan Rayment, Ralph G. Yount	45
16	Structural Model of the Regulatory Domain of Smooth Muscle Heavy Meromyosin 2003 ·Journal of Biological Chemistry ·Jan L. Wahlstrom, (unknown), J. David Lawson, Derek E. Lyons, William F. Siems, (unknown), (unknown), Kevin C. Facemyer, Christine Cremo	29
17	Intrinsic Disorder in Cell-signaling and Cancer-associated Proteins breakdown → 2002 ·Journal of Molecular Biology ·Lilia M. Iakoucheva, Celeste J. Brown, J. David Lawson, Zoran Obradović, A. Keith Dunker	989
18	Intrinsically disordered protein breakdown → 2001 ·Journal of Molecular Graphics and Modelling ·A. Keith Dunker, J. David Lawson, Celeste J. Brown, Ryan M. Williams, Pedro Romero, Jeong Seok Oh, Christopher J. Oldfield, Andrew Campen, (unknown), K. W. Hipps, Juan Ausió, M.S. Nissen, Raymond Reeves, ChulHee Kang, Charles R. Kissinger, Robert W. Bailey, Michael D. Griswold, Wah Chiu, Ethan C. Garner, Zoran Obradović	1823
19	The Roadford Scheme: Minimizing Environmental Impact on Affected Catchments 1991 ·Water and Environment Journal ·J. David Lawson, (unknown), David Solomon, (unknown)	7
20	DISCUSSION. THROUGH AND OVERFLOW ROCKFILL DAMS - NEW DESIGN TECHNIQUES. 1967 ·Proceedings of the Institution of Civil Engineers ·(unknown), (unknown), (unknown), (unknown), J. David Lawson, (unknown), (unknown), R. A. Sutherland, (unknown), (unknown), Pär-Erik Back, (unknown), (unknown), (unknown), (unknown)	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact